Reckitt Benckiser Group (LON:RB) Upgraded at UBS Group
Reckitt Benckiser Group (LON:RB) was upgraded by investment analysts at UBS Group to a “buy” rating in a research note issued on Monday, Borsen Zeitung reports. The firm currently has a GBX 8,400 ($103.37) price objective on the stock, up from their previous price objective of GBX 5,700 ($70.15). UBS Group’s price target points to a potential upside of 13.02% from the stock’s current price.
Several other research firms have also recently weighed in on RB. Citigroup reissued a “buy” rating on shares of Reckitt Benckiser Group in a report on Thursday, June 18th. Royal Bank of Canada set a GBX 4,900 ($60.30) target price on shares of Reckitt Benckiser Group and gave the stock a “sell” rating in a research report on Friday, June 5th. HSBC set a GBX 7,300 ($89.84) target price on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Morgan Stanley restated an “overweight” rating and set a GBX 7,000 ($86.14) target price on shares of Reckitt Benckiser Group in a research report on Monday, May 18th. Finally, CSFB restated a “neutral” rating on shares of Reckitt Benckiser Group in a research report on Thursday, April 30th. Two analysts have rated the stock with a sell rating, five have given a hold rating and thirteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of GBX 7,117.37 ($87.59).
Reckitt Benckiser Group stock opened at GBX 7,432 ($91.46) on Monday. The stock has a market cap of $52.69 billion and a P/E ratio of -14.28. The company has a quick ratio of 0.40, a current ratio of 0.56 and a debt-to-equity ratio of 130.80. Reckitt Benckiser Group has a twelve month low of GBX 5,130 ($63.13) and a twelve month high of GBX 8,191.30 ($100.80). The company’s 50-day moving average price is GBX 7,055.16 and its two-hundred day moving average price is GBX 6,393.24.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: How prevalent are 12b-1 fees?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.